Firstly, we assessed the benefit of cell line collections in signal seeking PARP inhibitor studies by systematically analysing cell lines from the Cancer Cell Line Encyclopedia (Broad, 2019) [8, 9, 10], accessed via cBioPortal. The gene discussed is PARP1; the disease is cancer.